Adverse Effects of Combined Tyrosine Kinase Inhibitors

被引：0
|
作者：
Lu, Shun [1 ]
Li, Ziming [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 11期
关键词：
INTERSTITIAL LUNG-DISEASE; CANCER; C797S; GEFITINIB; T790M;
D O I：
10.1016/j.jtho.2020.07.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E182 / E183
页数：2
相关论文
共 50 条
  • [21] Statins Enhance the Molecular Response in Chronic Myeloid Leukemia when Combined with Tyrosine Kinase Inhibitors
    Jang, Hyeok-Jae
    Woo, Young-Min
    Naka, Kazuhito
    Park, Jong-Ho
    Han, Ho-Jae
    Kim, Hee-Jin
    Kim, Sun-Hee
    Ahn, Jae-Sook
    Kim, Taehyung
    Kimura, Shinya
    Zarabi, Sarah
    Lipton, Jeffrey H.
    Minden, Mark D.
    Jung, Chul-Won
    Kim, Hyeoung-Joon
    Kim, Jong-Won
    Kim, Dennis Dong Hwan
    CANCERS, 2021, 13 (21)
  • [22] Role and mechanism of decitabine combined with tyrosine kinase inhibitors in advanced chronic myeloid leukemia cells
    Jiang, Li-Cai
    Luo, Jian-Min
    ONCOLOGY LETTERS, 2017, 14 (02) : 1295 - 1302
  • [23] Tyrosine Kinase Inhibitors and Male Reproductive Health
    Ramstein, Joris J.
    Tsai, Katy K.
    Smith, James F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (05) : 754 - 756
  • [24] Tyrosine kinase inhibitors in breast cancer (Review)
    Iancu, George
    Serban, Dragos
    Badiu, Cristinel Dumitru
    Tanasescu, Ciprian
    Tudosie, Mihai Silviu
    Tudor, Corneliu
    Costea, Daniel Ovidiu
    Zgura, Anca
    Iancu, Raluca
    Vasile, Danut
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 23 (02)
  • [25] Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer
    Ocana, Alberto
    Serrano, Rosario
    Calero, Raul
    Pandiella, Atanasio
    CURRENT DRUG TARGETS, 2009, 10 (06) : 575 - 576
  • [26] Tyrosine kinase inhibitors and pregnancy: A risk to the fetus?
    Jovelet, Cecile
    Broutin, Sophie
    Gil, Sophie
    Mir, Olivier
    Paci, Angelo
    BULLETIN DU CANCER, 2016, 103 (05) : 478 - 483
  • [27] Role of Tyrosine Kinase Inhibitors in Lung Cancer
    Ansari, J.
    Palmer, D. H.
    Rea, D. W.
    Hussain, S. A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (05) : 569 - 575
  • [28] Fasting plus tyrosine kinase inhibitors in cancer
    Caffa, Irene
    Longo, Valter D.
    Nencioni, Alessio
    AGING-US, 2015, 7 (12): : 1026 - 1027
  • [29] Mutations in the epidermal growth factor receptor gene and effects of EGFR-tyrosine kinase inhibitors on lung cancers
    Fukui T.
    Mitsudomi T.
    General Thoracic and Cardiovascular Surgery, 2008, 56 (3) : 97 - 103
  • [30] Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences
    Azzariti, Amalia
    Porcelli, Letizia
    Simone, Grazia M.
    Quatrale, Anna E.
    Colabufo, Nicola A.
    Berardi, Francesco
    Perrone, Roberto
    Zucchetti, Massimo
    D'Incalci, Maurizio
    Xu, Jian Ming
    Paradiso, Angelo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (02) : 335 - 346
12345